Northern California Clinical Research Center

Redding, California 96001

0 studies enrolling now · 7 studies all time

What they study most

Acute Migraine, Cardiovascular Disease, High Cardiovascular Risk, Influenza, Low Back Pain, Migraine Disorders, Migraine With or Without Aura, Obesity, Overweight, Prophylaxis: Influenza, Type 2 Diabetes

Studies at this site

• An Open-label, Long-term, Safety Study of Lasmiditan for the Acute Treatment of Migraine — Completed
• Three Doses of Lasmiditan (50 mg, 100 mg and 200 mg) Compared to Placebo in the Acute Treatment of Migraine — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed
• Safety and Immunogenicity of Two Trivalent Subunit Influenza Vaccines in Healthy Adult Subjects — Completed
• DFN-02 Open Label Safety Study in Patients With Acute Migraine — Completed
• Protective Efficacy of Flublok® Quadrivalent Versus Licensed Inactivated Influenza Vaccine in Adults ≥50 Years of Age — Completed
• Efficacy and Safety of Oxycodone/Naloxone Controlled-release Tablets (OXN) Compared to Placebo in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain — Completed